NCT05590689View on ClinicalTrials.gov

Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 9, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

January 31, 2027

Conditions
Glioblastoma
Interventions
DRUG

Gliolan

A repetitive dose of Gliolan will be administrated in combination with radiotherapy (radiodynamic therapy)

RADIATION

Radiodynamic therapy

Radiotherapy will be performed in combination with Gliolan administration

Trial Locations (1)

48149

RECRUITING

University Hospital Münster, Klinik für Neurochirurgie, Münster

All Listed Sponsors
collaborator

photonamic GmbH & Co. KG

INDUSTRY

lead

Universität Münster

OTHER